SouthState’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$542 Sell
1
-1
-50% -$517 ﹤0.01% 1251
2026
Q2
$1.08K Hold
2
– – ﹤0.01% 1097
2026
Q1
$1.19K Buy
2
+1
+100% +$498 ﹤0.01% 1008
2025
Q4
$488 Hold
1
– – ﹤0.01% 1244
2025
Q3
$420 Sell
1
-1
-50% -$336 ﹤0.01% 1265
2025
Q2
$575 Sell
2
-4
-67% -$1.2K ﹤0.01% 1407
2025
Q1
$1.85K Buy
+6
New +$2.06K ﹤0.01% 1202

Other funds holding UTHR

SouthState's UTHR Position: Q3 2026 in Review

SouthState reduced its United Therapeutics (UTHR) stake by 50% in Q3 2026, selling an estimated $517 and leaving 1 share worth $542. The position accounts for ﹤0.01% of the portfolio, ranked #1251.

SouthState first reported a position in UTHR in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.85K in Q1 2025. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • SouthState held 1 share of United Therapeutics worth $542 as of Q3 2026.
  • SouthState sold 1 United Therapeutics share in Q3 2026, an estimated $517.
  • United Therapeutics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1251 holding.
  • SouthState first reported a position in United Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • SouthState's United Therapeutics position peaked at $1.85K in Q1 2025.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.